Form 8-K - Current report:
SEC Accession No. 0001193125-23-066281
Filing Date
2023-03-09
Accepted
2023-03-09 17:17:32
Documents
21
Period of Report
2023-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d475718d8k.htm   iXBRL 8-K 44837
2 EX-4.2 d475718dex42.htm EX-4.2 359307
3 EX-4.6 d475718dex46.htm EX-4.6 351056
4 EX-5.1 d475718dex51.htm EX-5.1 18853
5 EX-5.2 d475718dex52.htm EX-5.2 14877
6 EX-5.3 d475718dex53.htm EX-5.3 41225
10 GRAPHIC g475718dsp10.jpg GRAPHIC 3961
11 GRAPHIC g475718dsp11.jpg GRAPHIC 2632
12 GRAPHIC g475718dsp6.jpg GRAPHIC 19375
13 GRAPHIC g475718dsp6a.jpg GRAPHIC 6537
  Complete submission text file 0001193125-23-066281.txt   1170797

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA teva-20230309.xsd EX-101.SCH 2856
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20230309_lab.xml EX-101.LAB 17167
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20230309_pre.xml EX-101.PRE 10792
15 EXTRACTED XBRL INSTANCE DOCUMENT d475718d8k_htm.xml XML 3309
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 23720706
SIC: 2834 Pharmaceutical Preparations